stockrowBiogen Inc.
BIIB Healthcare Drug Manufacturers General
Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- −104.4%
- Free cash flow
- −69.3%
- Total debt
- +16.0%
Quarter to September 2026, against a year earlier
Follow BIIB
Alert me
Biogen Inc. (BIIB) Operating margin
Biogen Inc.'s operating margin over the twelve months to 30 September 2026 was 7.53%, down 11.3 percentage points from fiscal 2025 (18.8%). Over the past ten years it has ranged from 16.4% (fiscal 2023) to 49.0% (fiscal 2019); the current reading is higher than 18% of that period. That is below the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 18.8% | (4.42) |
| FY2024 | 23.3% | 6.86 |
| FY2023 | 16.4% | (17.85) |
| FY2022 | 34.2% | 8.37 |
| FY2021 | 25.9% | (11.67) |
| FY2020 | 37.5% | (11.44) |
| FY2019 | 49.0% | 5.21 |
| FY2018 | 43.8% | 0.22 |
| FY2017 | 43.6% | (1.45) |
| FY2016 | 45.0% | (0.44) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 4.58% | (0.94) |
| Jun 2026 | 5.52% | (10.52) |
| Mar 2026 | 16.0% | 11.72 |
| Dec 2025 | 4.32% | (19.01) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| AZN AstraZeneca PLC compare | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| SNY Sanofi compare | 18.7% |
| GSK GSK PLC Sponsored ADR compare | 18.0% |
| BIIB Biogen Inc. | 7.53% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on BIIB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement